S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
Move Over Lithium – 220 Pounds of Graphite In Every EV Battery (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
What do Mastercard Earnings Indicate About Consumer Spending?
A gold storm is coming… (Ad)
How to Find Penny Stocks to Invest and Trade
What Tyson Foods Q1 Means For Staples Stocks
Apple, Amazon, and Walmart are Investing in Solar Energy (Ad)
ONSemi Is Marching Higher On Great Results
Can Cummins Power To A New High? 
S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
Move Over Lithium – 220 Pounds of Graphite In Every EV Battery (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
What do Mastercard Earnings Indicate About Consumer Spending?
A gold storm is coming… (Ad)
How to Find Penny Stocks to Invest and Trade
What Tyson Foods Q1 Means For Staples Stocks
Apple, Amazon, and Walmart are Investing in Solar Energy (Ad)
ONSemi Is Marching Higher On Great Results
Can Cummins Power To A New High? 
S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
Move Over Lithium – 220 Pounds of Graphite In Every EV Battery (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
What do Mastercard Earnings Indicate About Consumer Spending?
A gold storm is coming… (Ad)
How to Find Penny Stocks to Invest and Trade
What Tyson Foods Q1 Means For Staples Stocks
Apple, Amazon, and Walmart are Investing in Solar Energy (Ad)
ONSemi Is Marching Higher On Great Results
Can Cummins Power To A New High? 
S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
Move Over Lithium – 220 Pounds of Graphite In Every EV Battery (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
What do Mastercard Earnings Indicate About Consumer Spending?
A gold storm is coming… (Ad)
How to Find Penny Stocks to Invest and Trade
What Tyson Foods Q1 Means For Staples Stocks
Apple, Amazon, and Walmart are Investing in Solar Energy (Ad)
ONSemi Is Marching Higher On Great Results
Can Cummins Power To A New High? 
NASDAQ:TRVI

Trevi Therapeutics - TRVI Earnings Date, Estimates & Call Transcripts

$2.75
-0.22 (-7.41%)
(As of 02/6/2023 12:00 AM ET)
Add
Compare
Today's Range
$2.56
$2.97
50-Day Range
$1.74
$2.97
52-Week Range
$0.46
$4.68
Volume
102,310 shs
Average Volume
46,618 shs
Market Capitalization
$164.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.25

Earnings Summary

Upcoming
Earnings Date
Mar. 16Estimated
Actual EPS
(Nov. 10)
-$0.12 Beat By $0.03
Consensus EPS
(Nov. 10)
-$0.15
Last Year's Q4 EPS
(11/10/2021)
-$0.34
Skip Charts & View Estimated and Actual Earnings Data

TRVI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TRVI Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Trevi Therapeutics Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20231($0.09)($0.09)($0.09)
Q2 20231($0.10)($0.10)($0.10)
Q3 20231($0.10)($0.10)($0.10)
Q4 20231($0.11)($0.11)($0.11)
FY 20234($0.40)($0.40)($0.40)

TRVI Earnings Date and Information

Trevi Therapeutics last released its quarterly earnings data on November 10th, 2022. The reported ($0.12) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.15) by $0.03. Trevi Therapeutics has generated ($0.78) earnings per share over the last year (($0.78) diluted earnings per share). Earnings for Trevi Therapeutics are expected to grow in the coming year, from ($0.54) to ($0.45) per share. Trevi Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 16th, 2023 based off prior year's report dates.

Trevi Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/16/2023
(Estimated)
        
11/10/2022Q3 2022($0.15)($0.12)+$0.03($0.12)    
8/11/2022Q2 2022($0.21)($0.14)+$0.07($0.14)
5/12/2022Q1 2022($0.31)($0.24)+$0.07($0.24)    
3/17/2022Q4 2021($0.34)($0.28)+$0.06($0.28)    
11/10/20219/30/2021($0.33)($0.34)($0.01)($0.34)    
8/12/2021Q2 2021($0.46)($0.49)($0.03)($0.49)
5/13/20213/31/2021($0.49)($0.43)+$0.06($0.43)  
3/25/2021Q4 2020($0.45)($0.52)($0.07)($0.52)
11/12/20209/30/2020($0.59)($0.41)+$0.18($0.41)  
8/13/2020Q2 2020($0.51)($0.41)+$0.10($0.41)  
5/7/2020Q1 2020($0.44)($0.48)($0.04)($0.48)
3/16/2020Q4 2019($0.52)($0.19)+$0.33($0.19)
11/14/2019Q3($0.4750)($0.41)+$0.0650($0.41)
8/12/2019Q2 2019($0.41)($0.63)($0.22)($0.63)












Trevi Therapeutics Earnings - Frequently Asked Questions

When is Trevi Therapeutics's earnings date?

Trevi Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 16th, 2023 based off last year's report dates. Learn more on TRVI's earnings history.

Did Trevi Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Trevi Therapeutics (NASDAQ:TRVI) reported ($0.12) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.15) by $0.03. Learn more on analysts' earnings estimate vs. TRVI's actual earnings.

How can I listen to Trevi Therapeutics's earnings conference call?

The conference call for Trevi Therapeutics's latest earnings report can be listened to online. Listen to Conference Call

How can I read Trevi Therapeutics's conference call transcript?

The conference call transcript for Trevi Therapeutics's latest earnings report can be read online. Read Transcript

How much profit does Trevi Therapeutics generate each year?

Trevi Therapeutics (NASDAQ:TRVI) has a recorded net income of -$33.94 million. TRVI has generated -$0.78 earnings per share over the last four quarters.

What is Trevi Therapeutics's EPS forecast for next year?

Trevi Therapeutics's earnings are expected to grow from ($0.54) per share to ($0.45) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:TRVI) was last updated on 2/7/2023 by MarketBeat.com Staff